Viewing nowSimvastatin 40 mg Tablets (Simvastatin)
Simvastatin 40mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

MFDS item code 200301131 · Notified 2003.03.26 · Insurance code 640001040
Treatment of hyperlipidemia; improvement of pediatric heterozygous familial hypercholesterolemia; prevention of cardiovascular disease
This medication effectively reduces the risk of cardiovascular disease. It lowers the risk of death from coronary heart disease and the risk of non-fatal myocardial infarction and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke. It also reduces the risk after coronary and non-coronary vascular procedures. In patients with hyperlipidemia, it aids in reducing total cholesterol and LDL cholesterol levels, as well as controlling Apo-B protein and triglyceride levels. It is particularly effective in patients with genetic dyslipidemias such as familial hypercholesterolemia when used in conjunction with dietary therapy. It is also used for children over 10 years old with heterozygous familial hypercholesterolemia to improve cholesterol levels. This medication is used to maintain cardiovascular health and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose accordingly. Reduce the dose if the cholesterol level falls below the target. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients taking this medicine in combination with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when other lipid-lowering therapies are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with bile acid sequestrants. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, initiate treatment at 5 mg daily and monitor carefully.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Dose adjustments should be made at intervals of 4 weeks or longer.
This medication can cause muscle-related issues, potentially leading to myopathy or rhabdomyolysis. The risk can be increased, particularly when taken at high doses or in combination with certain medications. Patients with hypersensitivity to this medication, liver function impairment, pregnant or nursing women, and those taking powerful CYP3A4 inhibitors or certain medications should not take this medication. Patients with liver dysfunction, reduced kidney function, hypothyroidism, history of muscle disorders, elderly patients, and women should be especially cautious while taking this medication, and regular testing may be required. While taking this medication, if symptoms such as muscle pain, weakness, or tenderness occur, it is important to inform a doctor immediately and have testing done. If adverse symptoms are confirmed, discontinuation of the medication is necessary. Since this medication is metabolized in the liver, regular liver function tests should be conducted, and if symptoms of hepatitis or liver function abnormalities occur, discontinuation of the medication should be immediate. This medication can interact with several other drugs, so it is crucial to inform healthcare providers of the current medications being taken when starting new ones. Women who are pregnant or may become pregnant should avoid taking this medication, and if pregnancy is confirmed while on this medication, it should be discontinued immediately and consultation with healthcare professionals should be sought. In pediatric and adolescent cases, the medication is used restrictively only if specific ages and conditions are met, as it may affect growth and sexual maturation, hence caution is required. Elderly patients may have increased blood concentrations of this medication, leading to a higher possibility of muscle-related adverse reactions; therefore, regular monitoring is needed during use. In cases of overdose, general emergency measures should be implemented, and if suspected, immediate medical attention is necessary. This medication should be kept out of reach of children and stored in its original container to prevent quality deterioration or misuse.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. By storing it this way, the medication's effectiveness can be maintained for longer.
Pink oval film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 40mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.